BlueRock Therapeutics Revenue and Competitors

Claim your profile

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BlueRock Therapeutics's estimated annual revenue is currently $60.3M per year.(i)
  • BlueRock Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • BlueRock Therapeutics has 389 Employees.(i)
  • BlueRock Therapeutics grew their employee count by 46% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-99%N/AN/A
#2
$3.1M20233%N/AN/A
#3
$21.5M13918%$351MN/A
#4
$18M1165%$312.8MN/A
#5
$235M418-23%$340.9MN/A
#6
$2.2M3417%N/AN/A
#7
$6M40-9%$176.5MN/A
#8
$109.4M70614%N/AN/A
#9
$6.2M40233%N/AN/A
#10
$1.9M12-20%N/AN/A

BlueRock Therapeutics is a next-generation regenerative medicine company focused on breakthrough stem cell technology treatments of cardiovascular and neurodegenerative diseases. BlueRock Therapeutics has launched with the backing of a combined $225 million investment by Bayer and biotechnology investment firm Versant Ventures. BlueRock’s initial programs will focus on induced pluripotent stem cell (iPSC)-derived therapeutics to expand their technology pipeline.

keywords:N/A

N/A

Total Funding

389

Number of Employees

$60.3M

Revenue (est)

46%

Employee Growth %

N/A

Valuation

N/A

Accelerator

BlueRock Therapeutics News

2022-03-30 - Bayer reloads Leaps with €1.3 billion to step up investments in ...

In 2019, Bayer fully acquired BlueRock Therapeutics, a cell therapy developer it had formed three years earlier as a joint venture with...

2022-03-30 - Leaping forward: Bayer VC arm commits $1.4B to double investment ...

Some of Leaps' bets so far have been in cell therapy, including BlueRock Therapeutics, which Bayer eventually fully acquired for up to $600 million in 2019.

2022-03-30 - Bayer on keeping CGT acquisitions at arm's length - BioProcess ...

... innovation for cell and gene therapies, says Bayer's Jens Vogel. ... when it bought out cell therapy developer BlueRock Therapeutics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$50.4M39510%N/A
#2
$89.6M39855%N/A
#3
$1.8M4063%$538M
#4
$51.8M4065%N/A
#5
$74.1M4097%N/A